BILLERICA, Mass — EMD Millipore, the Life Science division of Merck KGaA of Darmstadt, Germany, today accepted the Chairman’s Award from Governor Deval Patrick at the Associated Industries of Massachusetts (AIM) Annual Meeting held in Waltham, MA. This award recognizes a Massachusetts firm, institution or public agency of any size that has demonstrated excellence in […]
AMSBIO offers a range of kits and reagents for the extraction (isolation) of high quality RNA from FFPE tissues and LCM samples that can be used not only for PCR but also microarray applications. Using AMSBIO ExpressArt® RNA isolation technology it is now possible to achieve high RNA yield and maximum sequence length from FFPE […]
CORALVILLE, IA – Integrated DNA Technologies (IDT), the world leader in oligonucleotide synthesis, has announced the launch of PrimeTime® qPCR Assay Plates, for high throughput qPCR analysis. Primers and probes for 5’-nuclease and intercalating dye assays (e.g., SYBR®) can now be directly ordered online in a 96 well plate format, eliminating the time-consuming transfer of […]
Agilent Technologies Inc. (NYSE: A) today reported orders of $1.69 billion, down 8 percent compared with one year ago, and revenues of $1.73 billion for the second fiscal quarter ended April 30, 2013, flat with one year ago. Second-quarter GAAP net income was $166 million, or $0.48 per share. Last year’s second-quarter GAAP net income […]
A breakthrough Charm® technology, WET, has been expanded to include the following ROSA mycotoxin tests: aflatoxin (USDA GIPSA approved), vomitoxin (DON or deoxynivalenol), fumonisin, zearalenone, ochratoxin, and T-2/HT-2 toxin. For the first time, mycotoxins in grain and feed can be safely and rapidly tested without the use of ethanol and methanol. Testing can now be […]
ALAMEDA, Calif.– BioTime, Inc. (NYSE MKT: BTX) today announced that Franklin M. Berger, CFA, 63, has been appointed to its Board of Directors. “We are pleased to welcome a recognized biotechnology industry expert of Franklin’s caliber to BioTime’s Board,” said Alfred D. Kingsley, Chairman of the Board of BioTime. “Franklin adds to our Board a […]
Golden, Colorado —— Vitro Diagnostics, Inc. (OTCQB: VODG), dba Vitro Biopharma, announced expansion of its distribution agreement with Neuromics to include targeted sales to select markets in drug discovery & regenerative medicine. Early stages of drug development rely on in-vitro assays to identify effective new drugs and these assays are based on cellular systems. Vitro […]
Patent Protection for TAL Effector Technology Enables Licensing Path for Life Technologies Customers
CARLSBAD, Calif., — Life Technologies Corporation (NASDAQ: LIFE) announced today the issuance of a new patent covering nucleic acids encoding Transcription Activator-Like Effector Nuclease fusion proteins (TALENS) and the formal launch of an associated sublicensing program. The technology has broad utility in the pharmaceutical industry, synthetic biology, and plant sciences for creating genetically modified cell […]
ST. LOUIS, — Sigma-Aldrich Corporation (Nasdaq: SIAL) today announced the launch of a novel scientific search engine designed to give researchers easier access to peer-reviewed articles and abstract information on the Company’s website, sigma-aldrich.com. The new search engine allows scientists to immediately read the full text of millions of peer-reviewed papers without extra clicks or […]
NITTO DENKO Avecia Inc., an industry leader in therapeutic nucleic acid manufacturing and development services, is proud to introduce a new pre-clinical oligonucleotide synthesis service, OliGrow. Combining phase appropriate quality and purity standards with a high level of customer service, the Avecia OliGrow team delivers pre-clinical oligonucleotides at ?mol to mmol scales, with affordable pricing […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
